Clinical Trials Arena on MSN

Zhongmou Therapeutics’ RP gene therapy shows promise in first-in-human trial

Zhongmou’s gene therapy has shown promise in treating the symptoms of retinitis pigmentosa (RP) in a single-site trial in China.
Business Wire

GenSight Biologics Reports Clinically Meaningful Vision Improvement is Maintained 4 Years After One-time Treatment with LUMEVOQ ® Gene Therapy

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies ...
Medscape

Thrombolysis Beneficial for ‘Eye Stroke’?

ABU DHABI, UAE — Thrombolysis to treat central retinal artery occlusion, also known as “eye stroke,” appeared to improve visual acuity compared with oral aspirin but this did not reach statical ...
Healio

Home acuity test shows high repeatability, agreement with in-clinic visual acuity

Please provide your email address to receive an email when new articles are posted on . “We are excited to be developing a simple test that clinicians can use to estimate the level of vision in ...
Healio

Drug preserves visual acuity in patients with choroidal melanoma

Please provide your email address to receive an email when new articles are posted on . Aura Biosciences announced positive visual acuity results from a phase 1b/2 trial of its cancer drug AU-011 in ...
MedPage Today

AAO Roundup: Glaucoma Subtype Linked to Alzheimer's Disease Risk

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- ...
JSTOR Daily

Gender Differences in Adapting Driving Behavior to Accommodate Visual Health Limitations

This is a preview. Log in through your library . Abstract This study investigated whether men and women are equally likely to adapt their driving behaviors in response to visual limitations.